These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25133894)

  • 1. Risk factor analysis of posterior reversible encephalopathy syndrome after allogeneic hematopoietic SCT in children.
    Zama D; Masetti R; Cordelli DM; Vendemini F; Giordano L; Milito G; Franzoni E; Porta F; Prete A; Rondelli R; Pession A
    Bone Marrow Transplant; 2014 Dec; 49(12):1538-40. PubMed ID: 25133894
    [No Abstract]   [Full Text] [Related]  

  • 2. Central Nervous System Complications and Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation.
    Bhatt VR; Balasetti V; Jasem JA; Giri S; Armitage JO; Loberiza FR; Bociek RG; Bierman PJ; Maness LJ; Vose JM; Fayad P; Akhtari M
    Clin Lymphoma Myeloma Leuk; 2015 Oct; 15(10):606-11. PubMed ID: 26184063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factor analysis of idiopathic pneumonia syndrome after allogeneic hematopoietic SCT in children.
    Sano H; Kobayashi R; Iguchi A; Suzuki D; Kishimoto K; Yasuda K; Kobayashi K
    Bone Marrow Transplant; 2014 Jan; 49(1):38-41. PubMed ID: 23955635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predisposing factors of posterior reversible encephalopathy syndrome in acute childhood leukemia.
    Kim SJ; Im SA; Lee JW; Chung NG; Cho B; Kim HK; Lee IG
    Pediatr Neurol; 2012 Dec; 47(6):436-42. PubMed ID: 23127265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posterior reversible encephalopathy syndrome concurrent with human herpesvirus-6B encephalitis after allogeneic hematopoietic stem cell transplantation.
    Ito Y; Toyama K; Honda A; Nakazaki K; Arai S; Kurokawa M
    J Infect Chemother; 2020 Feb; 26(2):265-268. PubMed ID: 31421950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcineurin inhibitor-free strategies for prophylaxis and treatment of GVHD in children with posterior reversible encephalopathy syndrome after stem cell transplantation.
    Shkalim-Zemer V; Konen O; Levinsky Y; Michaeli O; Yahel A; Krauss A; Yaniv I; Stein J
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28417553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posterior Reversible Encephalopathy Syndrome in Children With Hematologic Malignancies.
    Tavares M; Arantes M; Chacim S; Júnior AC; Pinto A; Mariz JM; Sonin T; Pereira S
    J Child Neurol; 2015 Oct; 30(12):1669-75. PubMed ID: 25862738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe hypertension is an independent risk factor for posterior reversible encephalopathy syndrome post-hematopoietic cell transplantation in children with thalassemia major.
    Li XY; Huang K; Zhou DH; Li Y; Xu HG; Weng WJ; Xu LH; Fang JP
    Clin Transplant; 2019 Jan; 33(1):e13459. PubMed ID: 30506735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychological distress as a negative survival factor for patients with hematologic malignancies who underwent allogeneic hematopoietic stem cell transplantation.
    Park JE; Kim KI; Yoon SS; Hahm BJ; Lee SM; Yoon JH; Shin WG; Lee HS; Oh JM
    Pharmacotherapy; 2010 Dec; 30(12):1239-46. PubMed ID: 21114391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in children with PRES and hematologic diseases.
    Tambasco N; Mastrodicasa E; Salvatori C; Mancini G; Romoli M; Caniglia M; Calabresi P; Verrotti A
    Acta Neurol Scand; 2016 Dec; 134(6):474-483. PubMed ID: 26876986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic treatment for hypertension and seizure in a case of allogeneic hematopoietic stem cell transplantation after posterior reversible encephalopathy syndrome.
    Fukuyama T; Tanaka M; Nakazawa Y; Motoki N; Inaba Y; Higuchi T; Koike K
    Pediatr Transplant; 2011 Dec; 15(8):E169-73. PubMed ID: 20735807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posterior Reversible Encephalopathy Syndrome in Children:: A Prospective Follow-up Study.
    Darwish AH
    J Child Neurol; 2020 Jan; 35(1):55-62. PubMed ID: 31570037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Encephalopathy in pediatric patients after allogeneic hematopoietic stem cell transplantation is associated with a poor prognosis.
    Woodard P; Helton K; McDaniel H; Khan RB; Thompson S; Hale G; Benaim E; Kasow K; Leung W; Horwitz E; Srivastava DK; Tong X; Yusuf U; Cunningham JM; Handgretinger R
    Bone Marrow Transplant; 2004 Jun; 33(11):1151-7. PubMed ID: 15077130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults.
    Mehta RS; Peffault de Latour R; DeFor TE; Robin M; Lazaryan A; Xhaard A; Bejanyan N; de Fontbrune FS; Arora M; Brunstein CG; Blazar BR; Weisdorf DJ; MacMillan ML; Socie G; Holtan SG
    Haematologica; 2016 Jun; 101(6):764-72. PubMed ID: 27036159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial.
    Peters C; Schrappe M; von Stackelberg A; Schrauder A; Bader P; Ebell W; Lang P; Sykora KW; Schrum J; Kremens B; Ehlert K; Albert MH; Meisel R; Matthes-Martin S; Gungor T; Holter W; Strahm B; Gruhn B; Schulz A; Woessmann W; Poetschger U; Zimmermann M; Klingebiel T
    J Clin Oncol; 2015 Apr; 33(11):1265-74. PubMed ID: 25753432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etiology, characteristics and outcome of seizures after pediatric hematopoietic stem cell transplantation.
    Cordelli DM; Masetti R; Zama D; Gueraldi D; Rondelli R; Cottone C; Prete A; Pession A; Franzoni E
    Seizure; 2014 Feb; 23(2):140-5. PubMed ID: 24287078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features of encephalopathy in children with cancer requiring cranial magnetic resonance imaging.
    Lim YJ; Kim HJ; Lee YJ; Seol IJ; Lee YH
    Pediatr Neurol; 2011 Jun; 44(6):433-8. PubMed ID: 21555054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candida is an emerging pathogen beyond the neutropenic period of allogeneic hematopoietic cell transplantation.
    Sakellari I; Gavriilaki E; Kaliou M; Mallouri D; Batsis I; Yannaki E; Smias C; Sotiropoulos D; Tsorlini E; Anagnostopoulos A
    Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28224660
    [No Abstract]   [Full Text] [Related]  

  • 19. Posterior reversible encephalopathy syndrome in pediatric patients: pathophysiology, diagnosis, and management.
    Ghali MGZ; Davanzo J; Leo M; Rizk E
    Leuk Lymphoma; 2019 Oct; 60(10):2365-2372. PubMed ID: 31556774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and implications of oral mucositis in recipients of allogeneic hematopoietic stem cell transplantation.
    Shouval R; Kouniavski E; Fein J; Danylesko I; Shem-Tov N; Geva M; Yerushalmi R; Shimoni A; Nagler A
    Eur J Haematol; 2019 Oct; 103(4):402-409. PubMed ID: 31332836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.